We can’t show the full text here under this license. Use the link below to read it at the source.
A Retrospective Study of Treatment Outcomes and Prognostic Factors of Intense Pulsed Light Therapy Combined With Meibomian Gland Expression in Patients With Meibomian Gland Dysfunction
Treatment results and factors linked to success for intense light therapy combined with gland expression in dry eye patients
AI simplified
Abstract
Significant improvements were observed in several clinical measures after three /MGX treatments in 44 patients with .
- Standard Patient Evaluation of Eye Dryness, Ocular Surface Disease Index, tear break-up time, corneal fluorescein staining score, meibomian gland yielding secretion score, meibomian glands yielding clear secretion, and meibomian glands yielding liquid secretion showed significant improvement post-treatment.
- Meiboscore and meibomian gland loss score did not change after treatment.
- Younger patients with better treatment outcomes had a mean age of 36.0 years compared to 53.0 years for less responsive patients.
- Patients with longer tear break-up times and better meiboscores demonstrated greater improvements in meibomian gland yielding secretion scores.
- Changes in meibomian gland yielding secretion scores were notably higher in patients with lower meiboscores and meibomian gland secretion scores before treatment.
AI simplified
Key numbers
12.5
Decrease in SPEED Score
SPEED score decreased from (18.5, 6.0) to (6.0, 6.75)
36.0 years
Average Age of Responsive Patients
Compared to 53.0 years for nonresponsive patients
12.0
Improvement in MGYSS
Patients with MGYSS of 0 to 1 before treatment